Tritonix.ai

News / Taiwan / economic_daily

Taiwan Stocks Face Volatility as Nvidia Earnings and Fed Policy Loom; Pei-Er Biomedical Hits Record High

Health Technology · Biotechnology · economic_daily · 2026-08-25

2059, 3231, 5274, 6446, 6949

Taiwan stocks retreated as investors braced for Nvidia's earnings and Fed commentary, while biotech firm Pei-Er Biomedical bucked the trend to reach a new record.

What Happened

Market Volatility: The Taiwan stock market experienced significant intraday volatility, briefly dipping below the monthly moving average as selling pressure intensified. High-priced stocks faced downward pressure, with industry leader Aspeed falling below its six-month moving average.

Macroeconomic Uncertainties: Investors are cautious ahead of Nvidia's upcoming quarterly results and the Federal Reserve's annual Jackson Hole symposium. Persistent concerns over high U.S. Treasury yields continue to weigh on market sentiment despite government efforts to manage long-term debt.

Biotech Resilience: Amid the broader market decline, capital has rotated into defensive sectors including biotechnology and shipping. Pei-Er Biomedical stood out as a notable performer, surging over 6% to reach a new all-time high above 1,300 TWD.

Company Development: Pei-Er Biomedical specializes in immune cell therapies and has successfully completed Phase II clinical trials for its CAR-T agent, PL001. The company is currently seeking regulatory approval with the goal of launching the product by early next year.

Read original

More in Health Technology

DS Investment Securities Raises Hanmi Pharmaceutical Target Price on Obesity Drug Licensing Deal

Health Technology · yonhap_finance · 2026-08-24

DS Investment Securities raised Hanmi Pharmaceutical's target price to 720,000 KRW, citing increased clinical success potential following a major licensing deal.

128940

PharmaEssentia's Ropeg Secures Regulatory Approval in Japan for ET Treatment

Health Technology · economic_daily · 2026-08-24

PharmaEssentia's innovative interferon Ropeg has received approval from Japan's MHLW for the treatment of essential thrombocythemia, covering all patient segments.

6446

Taiwan Ranks First in Global Healthcare Index for 8th Year; Premier Cho Pledges to Build New 'National Shield' in Biotech

Health Technology · cnyes · 2026-08-24

Premier Cho Jung-tai announced that Taiwan's biotech sector will be the next pillar of the economy, backed by massive AI infrastructure investments.

Latest in Taiwan

Allianz Global Investors Launches Taiwan's First Active Asian Semiconductor ETF to Capture AI Growth

Electronic Technology · economic_daily · 2026-08-25

Allianz has introduced an active ETF focusing on the Asian semiconductor supply chain, aiming to leverage the region's dominance in AI-driven technology.

00412

Taiwan Stocks Face Low Volume as Investors Pivot to ETFs Amid Market Uncertainty

Miscellaneous · economic_daily · 2026-08-25

Taiwan stocks struggled with low trading volumes and a breach of the monthly moving average, while ETFs dominated the most active trading lists.

00403, 00406, 0050, 00631, 00685, 00981, 2317, 2327

Nvidia Earnings in Focus: Analysts Pinpoint Gross Margin as Key for Taiwan Stocks

Electronic Technology · economic_daily · 2026-08-25

As Taiwan stocks face a period of low-volume consolidation, analysts highlight Nvidia's upcoming gross margin figures as the critical catalyst for market direction.

Taiwan Stocks Slip Below Monthly Moving Average as Investors Pivot to Value Plays

Electronic Technology · economic_daily · 2026-08-25

Taiwan stocks fell 462 points on Tuesday, dragged down by a sharp decline in the Philadelphia Semiconductor Index, as investors shifted focus toward secondary semiconductor and legacy AI stocks.

2303, 2330